Stay updated on Combination Immunotherapy in Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the Combination Immunotherapy in Prostate Cancer Clinical Trial page.

Latest updates to the Combination Immunotherapy in Prostate Cancer Clinical Trial page
- Check5 days agoChange DetectedRevision: v3.4.3 added; Prostate cancer, related topics, MedlinePlus Genetics, and Revision: v3.4.2 removed.SummaryDifference0.1%

- Check12 days agoChange DetectedAdded related topics Prostate cancer and MedlinePlus Genetics to the page's related topics section; this provides extra context for readers without changing the trial details.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check33 days agoChange DetectedAddition: Revision: v3.4.2 is shown, and older Revision: v3.4.1 references and Prostate cancer topic links were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check41 days agoChange DetectedAdded a government funding notice banner with links to cc.nih.gov and opm.gov, plus related Prostate Cancer topic links and a revision note (v3.4.1); the previous revision entry (v3.4.0) was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check48 days agoChange DetectedAdded long-term outcome definitions (rPFS, TTR-PCWG3, DOR-PCWG3, TTP-PSA) with timeframes up to 84 months and related metric descriptions. Introduced Brazil locations (Rio de Janeiro and São Paulo) with addresses and a 'Show glossary' option on the page.SummaryDifference2%

- Check62 days agoChange DetectedAdded Revision: v3.3.4 and removed Revision: v3.3.3 from the page.SummaryDifference0.0%

Stay in the know with updates to Combination Immunotherapy in Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Combination Immunotherapy in Prostate Cancer Clinical Trial page.